反応式
CC1(C)C(C)(C)OB([C:9]2[CH:17]=[C:16]([C:18]([F:21])([F:20])[F:19])[CH:15]=[C:14]3[C:10]=2[CH:11]=[N:12][NH:13]3)O1.Br[C:24]1[C:25]([O:32][CH3:33])=[N:26][C:27]([O:30][CH3:31])=[N:28][CH:29]=1.[C:34](=[O:37])([O-])[O-:35].[Na+].[Na+]>O1CCOCC1.C1C=CC(P(C2C=CC=CC=2)[C-]2C=CC=C2)=CC=1.C1C=CC(P(C2C=CC=CC=2)[C-]2C=CC=C2)=CC=1.Cl[Pd]Cl.[Fe+2]>[C:34]([OH:35])([C:18]([F:21])([F:20])[F:19])=[O:37].[CH3:31][O:30][C:27]1[N:26]=[C:25]([O:32][CH3:33])[C:24]([C:9]2[CH:17]=[C:16]([C:18]([F:19])([F:20])[F:21])[CH:15]=[C:14]3[C:10]=2[CH:11]=[N:12][NH:13]3)=[CH:29][N:28]=1参加物
反応物 3
生成物 2
試薬・触媒・溶媒 2
反応条件
- 温度
- 130 °C
実験手順
4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-6-(trifluoromethyl)-1H-indazole (35 mg, 0.112 mmol), 5-bromo-2,4-dimethoxypyrimidine (24.56 mg, 0.112 mmol), and PdCl2(dppf) (8.21 mg, 0.011 mmol) were dispersed in dioxane (1.5 mL). To the resulting slurry was added 2N aqueous sodium carbonate (0.112 mL, 0.224 mmol). The mixture was purged with nitrogen, heated in a microwave reactor at 130° C. for 50 minutes, and then filtered through a microfiltration frit. Dioxane was stripped with nitrogen. The resulting residue was taken up in DMSO and methanol (1:1) and was purified via preparative HPLC, eluting with a gradient of ACN (containing 0.035% TFA) in H2O (containing 0.05% TFA). The purified fractions were collected to give a TFA salt of the title compound (8.2 mg, 23%). ESI-MS m/z [M+H]+ calc'd for C14H11F3N4O2, 325.1. found 325.2.
後処理
- customThe mixture was purged with nitrogen
- filtrationfiltered through a microfiltration frit
- custommethanol (1:1) and was purified via preparative HPLC
- washeluting with a gradient of ACN (containing 0.035% TFA) in H2O (containing 0.05% TFA)
- customThe purified fractions were collected
出典と根拠
- ORDレコード
- ord-c1a4f9d86256414cb555e8b9c9efc9c1
- 出典データセット
- uspto-grants-2016_09
- 特許番号
- US09434743B2
関連ノート
読み込み中…